Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Shareholder meetings

2025 General Meeting

Next Science will hold a General Meeting on Thursday, 28 August 2025 at 9:00am (Sydney time).

Information
Notice of MeetingOpens in new window
Independent Expert ReportOpens in new window
Addendum to Notice of General MeetingOpens in new window

Investor contacts

Investor queries

Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 412 292 977
E: [email protected]

Share Registry queries

Automic
Level 5, 126 Phillip Street
Sydney NSW 2000
Email: [email protected]
Ph (within Australia): 1300 288 664
Ph (outside Australia): +61 2 9698 5414